Ignite Creation Date:
2025-12-24 @ 1:48 PM
Ignite Modification Date:
2025-12-30 @ 7:25 AM
Study NCT ID:
NCT05740995
Status:
RECRUITING
Last Update Posted:
2023-03-21
First Post:
2023-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Sponsor:
Shanghai Zhongshan Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-14
First Submit QC Date:
None
Study First Post Date:
2023-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-17
Last Update Post Date:
2023-03-21
Last Update Post Date Type:
ACTUAL